BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today announced that the Company has been recognized for its diverse and flexible workplace by Forbes and FlexJobs.
PAREXEL has been named to Forbes’ new “America’s Best Employers for Diversity” list recognizing the top 250 employers across all industries. Results are based on independent survey responses from more than 30,000 employees working for companies from all industry sectors as well as examination of employer diversity policies and diversity in executive suites and boards. This is the third time that PAREXEL has been recognized by Forbes for its employment practices. In 2016 and 2017, Forbes named PAREXEL to its “America’s Best Employers” list.
PAREXEL was also recognized by FlexJobs as a “Top 100 Company to Watch for Remote Jobs in 2018,” its fifth consecutive time on the list. The list recognizes companies that are remote-friendly, allowing for employees to telecommute either on a full- or part-time basis. PAREXEL offers its nearly 20,000 global employees flexible work options, including telecommuting, flexible schedules, and home-based employment. These employees represent a diverse cross section of positions, including clinical research, biostatistics and regulatory affairs.
“At PAREXEL, the important work we do on behalf of our clients seeking to prevent and cure disease demands the expertise that comes with global and diverse representation, as well as flexibility and local presence,” said Tom McGoldrick, Corporate Vice President of Talent Acquisition, PAREXEL. “We have always believed that providing a diverse, inclusive and flexible work environment that engages and inspires ultimately allows our employees to flourish and deliver for our clients. We are thrilled to see this commitment recognized by Forbes and FlexJobs.”
To learn more about career opportunities at PAREXEL, please visit www.jobs.PAREXEL.com.
About PAREXEL International
PAREXEL International Corporation is the world’s leading innovator of biopharmaceutical services. We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services. PAREXEL develops breakthrough innovations and solutions by leveraging its comprehensive therapeutic, technical and functional expertise, in more than 100 countries around the world. For more information visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.
